What should be done if a scheduled intravenous (IV) dose of Rocephin (ceftriaxone) is missed? | Rounds What should be done if a scheduled intravenous (IV) dose of Rocephin (ceftriaxone) is missed? | Rounds
Loading...

What should be done if a scheduled intravenous (IV) dose of Rocephin (ceftriaxone) is missed?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2026 · View editorial policy

Missed IV Ceftriaxone (Rocephin) Dose

A missed scheduled dose of ceftriaxone should be given as soon as possible after the miss is identified. [1][2] A double dose should not be administered to compensate for the missed dose. [1][2] Skipping doses or not completing the full course of therapy can decrease effectiveness and increase the likelihood of bacterial resistance. [4]

Immediate Action After Dose Miss

  • The missed scheduled ceftriaxone dose should be administered as soon as it is remembered. [1][2]
  • The next scheduled dose should be continued after administration of the missed dose, without doubling. [1][2]
  • If the missed dose is not administered promptly, the responsible clinician or antibiotic-ordering team should be notified to adjust the schedule. [2]

Double-Dosing Avoidance

  • A double dose should not be used to make up for a missed ceftriaxone dose. [1][2]

Treatment Continuity Priorities

  • Ceftriaxone therapy should be completed as prescribed to reduce the risk of incomplete treatment. [1]
  • Skipping doses or incomplete completion of therapy increases resistance risk. [4]

Monitoring After Missed Dose Correction

  • Ongoing clinical monitoring for failure to respond to therapy should occur if doses are missed or therapy is delayed. [1]
  • Adverse effect monitoring should continue per ceftriaxone treatment plan, since diarrhea can occur during therapy and sometimes after therapy completion. [4]

When Additional Clinical Input Is Required

  • If multiple doses are missed, urgent clinical review should occur to prevent inadequate treatment and resistance development. [4]
  • If administration timing uncertainty exists (for example, when the next scheduled dose is imminent), the prescriber or pharmacy should determine the adjusted administration plan rather than administering an extra dose. [2]

Continuation of Scheduled Dosing

  • After the missed dose is addressed, ceftriaxone dosing should proceed on the original schedule unless a clinician provides a new dosing plan. [1][2]

Related Questions